Lv3
388 积分 2021-08-13 加入
The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer
1个月前
已完结
Anti-CD19/CD8 bispecific T cell engager for the potential treatment of B cell malignancies
2个月前
已完结
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers
4个月前
已完结
SAGE library screening reveals ILT7 as a specific plasmacytoid dendritic cell marker that regulates type I IFN production
4个月前
已关闭
Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus
5个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
6个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
6个月前
已完结
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
6个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
6个月前
已完结
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
6个月前
已完结
皖公网安备34019202002308
